Pharma’s willingness to embrace creativity is gathering speed

In our cover story, Chris Ross explores innovation in healthcare comms and asks if pharma can ditch its cautious approach to creativity in comms. Chris notes that, unsurprisingly, the past 18 months have seen gargantuan change – companies are exploring new ways of thinking and communicating, and it’s driving increased appreciation of the value of creativity. The article goes on to talk about how pharma’s willingness to embrace creativity has been gathering speed, and that communicating the science has gone from penny-farthing to speedway bike in a matter of months. Read more on page 26.

In our article on Alzheimer’s disease and beyond, Simon Lovestone, VP, Disease Area Stronghold lead in Neurodegeneration at Janssen shares some sobering information that Alzheimer’s disease, and its related disorders, is one of humanity’s greatest unmet medical needs, and deaths due to Alzheimer’s rival those due to COVID-19 in many countries. He goes on to talk about how pathology-based drug development, precision medicine and a diversification of targets all herald a promising future for therapies in neurodegeneration. Read more on page 16.

Also in this issue, Mike Crichton talks about how GSK is continuing to advance the science in respiratory medicine and how, in response to the pandemic, the company has adapted in order to continue supporting patients with conditions such as asthma and COPD. Read more on page 20.

In October we have a separate supplement from Amarin on Rethinking Cardiovascular Risk. The supplement includes commentary from Karim Mikhail, President and CEO, Christos Papadopoulos, European Head Commercial Excellence and Tatyana Tyx, Head of Marketing for Europe, all at Amarin. The insert focuses on the opportunity to change the treatment paradigm in preventative cardiovascular care across Europe and the challenge of launching a new product across multiple European markets.

Looking ahead, in our November issue we will be focusing on how remote patient monitoring is set to change the healthcare industry forever.

If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com

I hope you enjoy this issue!

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register